Chatbots Archives - PharmaLive

“What Elon Musk’s Twitter Takeover Could Mean for Advertisers”

Acquisitions, Advertisements, Business, Chatbots, Elon Musk, Healthcare Communications Agencies, Influencer Marketing, Marketing & Advertising, Social media, Speech, Twitter

Elon Musk struck a deal to buy Twitter for $44 billion. Although a somewhat unconventional character, sleeping at the Tesla headquarters and eschewing wealthy materialism, make no mistake that Musk’s successful track record in business shows how significant Twitter may become under his leadership. While no one knows for sure what will be, Casey Ross – Social Media Strategy Director at FCB Health New York – looks at some of the issues Musk has publicly called out, and their potential implications for advertisers.

April 29, 2022/by Andrew Humphreys

Chatbot Therapy: It’s Quite Effective… but It Can’t Give You a Hug

Apps, British Columbia, Chatbots, Cognitive Behavioral Therapy, Data, Doctors, Google, Mental Health, Smart Devices, Studies

Studies have concluded that chatbots have the potential in treating mental health issues and could be used as an effective tool for delivering cognitive behavioral therapy.

April 1, 2021/by Andrew Humphreys

The ABCDs of a rare disease launch

Chatbots, Issue Archives, June 2019, Patients, Personalized Medicine, Physicians, Rare Diseases, Rare Diseases

The first rule of rare: There are no rules. There are over 7,000 different rare diseases – each with its own symptomology, history, and clinical and political landscape. Most are virgin territory for marketers; only 5 percent have an approved treatment.

June 6, 2019/by Administrator

Voice, the next generation

Chatbots, Issue Archives, June 2019, Pharma, Voice interface

It’s clearly what’s next, but to take advantage of voice device interactions pharma will have to retune its content development and review processes.

June 6, 2019/by Administrator

Artificial intelligence generated plenty of chatter amongst the pharma marketing intelligentsia in 2018. Will 2019 be the year when the industry fully embraces it as more than just a tactic?

February 13, 2019/by Joshua Slatko

Intouch Solutions’ Sean Hartigan and Heartbeat’s David Sakadelis say their pharma clients are skittish about the use of chatbots and AI, with an understanding of these technologies more influenced by the grim future of Skynet in the “Terminator” movie franchise rather than the reality of where AI is right now.

December 12, 2018/by Christiane Truelove

Top Trends in Digital Health in 2019

Apple Watch, Blockchain, Chatbots, Consumers, Digital Health, DTC, Electrocardiogram (EKG) Technology, FDA, Health Data, Medical Devices, Patient Engagement, Smart Pills, Surveys

2018 was the year of the consumer, and there is no sign of a change any time soon.

December 6, 2018/by Administrator

Five Key Digital Insights for Your Brand from Digital Pharma West

Ad agency blogging, Artificial Intelligence, Augmented Reality, August 2017, Chatbots, Digital Marketing, Facebook, Healthcare Physicians, Marketing & Advertising, Social media, Virtual Reality

From the latest in VR to imaginative Social Engagement approaches, here are Ben Putman’s Top Five Digital Marketing takeaways for 2017.

July 13, 2017/by Administrator

DTC Special Feature: A view of the future

Chatbots, Consumers, DTC, Healthcare Physicians, June 2017, Virtual Reality

Med Ad News asked industry experts what they thought DTC communications might look like in five years. This is what they told us.

June 9, 2017/by Administrator

5 Key Strategies to Enhance Social Media Marketing Campaigns

Chatbots, Digital, Facebook, Healthcare Physicians, Marketing & Advertising, Obamacare, Pharma, Reports, Social media, Twitter

Social media is integrated into the daily lives of consumers, often engaging with brands for customer service support – except when it comes to pharmaceutical companies.

March 10, 2017/by Administrator